Strides Pharma reports September-quarter revenue of 14.3 billion rupees
Strides Pharma Science Ltd. reported consolidated revenue from operations of 14.3 billion rupees for the September quarter.
Related stories
Eli Lilly Raises Revenue Forecast as Shares Surge
Higher revenue guidance offsets weaker-than-expected results for its weight-loss injections and Foundayo.
M impact | EARNINGS | Oct 29, 2026, 02:13 PM UTC
Eli Lilly Raises Revenue Outlook as Weight-Loss Shots Offset Foundayo Sales Miss
Eli Lilly raised its revenue outlook, with weight-loss shot sales offsetting a Foundayo sales miss; its shares jumped.
M impact | EARNINGS | Oct 29, 2026, 02:12 PM UTC
Bristol Myers Squibb Sees FY Adjusted Revenue at $49.75B-$50.25B
M impact | EARNINGS | Oct 29, 2026, 02:12 PM UTC
TSX Slips on Mining Losses
The S&P/TSX Composite Index slipped below 36,500 on Thursday, weighed down by losses in the mining sector as falling gold prices pressured major producers. Agnico Eagle fell nearly
H impact | EARNINGS | Oct 29, 2026, 02:08 PM UTC
Indegene Reports September-Quarter Revenue of 11.22 Billion Rupees
L impact | EARNINGS | Oct 29, 2026, 02:08 PM UTC
Indegene Reports September-Quarter Consolidated Net Profit of 1.12 Billion Rupees
M impact | EARNINGS | Oct 29, 2026, 02:08 PM UTC